Previous close | 13.70 |
Open | N/A |
Bid | 12.50 |
Ask | 15.20 |
Strike | 210.00 |
Expiry date | 2025-04-17 |
Day's range | 13.70 - 13.70 |
Contract range | N/A |
Volume | |
Open interest | 50 |
Ferrari, Vertex, ResMed and Hubbel have been highlighted in this Screen of The Week article.
Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.